TrialThe Lancet. Neurology2014

Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study.

Sondra W Levin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.